Avg closing price
Price range

3 Seth Klarman Nuvation Bio Trades

Seth Klarman's position in Nuvation Bio is currently worth $20.6 Million. That's 0.31% of their equity portfolio (30th largest holding). The investor owns 5.13% of the outstanding Nuvation Bio stock. Seth Klarman started to build up the position in Nuvation Bio in Q1 2021 and continued to invest until Q1 2022. Since then they sold 25.3 Thousand shares. The investor's estimated purchase price is $109 Million, resulting in a loss of 81%.

Avg closing price
Price range
Sold 0.2% shares (-25.3 Thousand shares) Q2 2022
Avg closing price $4.36
Price range $3.24 - $5.85
Increased shares by 21.1% (+1.82 Million shares) Q1 2022
Avg closing price $5.62
Price range $4.60 - $8.83
New holding (+8.62 Million shares) Q1 2021
Avg closing price $11.47
Price range $9.00 - $14.57

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!